Cargando…
Natural and synthetic 2-oxoglutarate derivatives are substrates for oncogenic variants of human isocitrate dehydrogenase 1 and 2
Variants of isocitrate dehydrogenase (IDH) 1 and 2 (IDH1/2) alter metabolism in cancer cells by catalyzing the NADPH-dependent reduction of 2-oxoglutarate (2OG) to (2R)-hydroxyglutarate. However, it is unclear how derivatives of 2OG can affect cancer cell metabolism. Here, we used synthetic C3- and...
Autores principales: | Liu, Xiao, Reinbold, Raphael, Liu, Shuang, Herold, Ryan A., Rabe, Patrick, Duclos, Stéphanie, Yadav, Rahul B., Abboud, Martine I., Thieffine, Sandrine, Armstrong, Fraser A., Brewitz, Lennart, Schofield, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939733/ https://www.ncbi.nlm.nih.gov/pubmed/36621625 http://dx.doi.org/10.1016/j.jbc.2023.102873 |
Ejemplares similares
-
Exploiting Electrode Nanoconfinement to Investigate
the Catalytic Properties of Isocitrate Dehydrogenase (IDH1) and a
Cancer-Associated Variant
por: Herold, Ryan A., et al.
Publicado: (2021) -
Differentiating
Inhibition Selectivity and Binding
Affinity of Isocitrate Dehydrogenase 1 Variant Inhibitors
por: Liu, Shuang, et al.
Publicado: (2023) -
Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitors
por: Reinbold, Raphael, et al.
Publicado: (2022) -
Roles of metal ions in the selective inhibition of oncogenic variants of isocitrate dehydrogenase 1
por: Liu, Shuang, et al.
Publicado: (2021) -
Synthesis of 2-oxoglutarate derivatives and their evaluation as cosubstrates and inhibitors of human aspartate/asparagine-β-hydroxylase
por: Brewitz, Lennart, et al.
Publicado: (2020)